tirzepatide nash phase 3 Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one in three adults worldwide, yet many cases remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? Lilly's Tirzepatide Reduced Heart Failure

peer review: 2 approved]

TRANSCEND-T2D-1 (NCT06354660) will compare the efficacy and safety of retatrutide compared to placebo in people with inadequately controlled T2D treated with diet and exercise over a period of 11 months

International journal of preventive medicine, 13, 144

Sermorelin has gained attention as an alternative to growth hormone supplementation because its mechanism of action appears to result in fewer side effects

Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk

Accordingly, while the direction of effects appears broadly consistent across systems, the precision of the estimated magnitudes should be interpreted with caution